Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in Days.
The item "Cash-Conversion-Cycle" stands at 174.53 days as of 09/30/2025.
As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Cash Conversion Cycle" stands at 174.53 Days. This represents an increase of 3.10 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -12.67 percent compared to the value the year prior.
The 1 year change in percent is -12.67.
The 3 year change in percent is 24.85.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash Conversion Cycle | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash Conversion Cycle | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Conversion Cycle | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash Conversion Cycle | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash Conversion Cycle | 280,205,508,085.11 |